The IASB has published a consultation in the form of an exposure draft proposing targeted amendments to clarify which investments a company is eligible to measure using the fair value option in IAS 28 Investments in Associates and Joint Ventures.

The consultation is open until 20 April 2026 and the IASB plans to finalise any amendments by mid-2026, allowing jurisdictions to bring the amendments into national legislation.

EFRAG has published its Draft Comment Letter ('DCL') on the IASB's Exposure Draft (ED’) Amendments to the Fair Value Option for Investments in Associates and Joint Ventures - Proposed amendments to IAS 28. Stakeholders are invited to comment on EFRAG’s DCL by 7 April 2026.

EFRAG supports the IASB’s proposed amendments as they would address insurers’ concerns over divergent interpretations of ‘similar entities’ in paragraphs 18 and 19 of IAS 28 Investments in Associates and Joint Ventures, and the subsequent impact on classification between operating and investing categories under IFRS 18 Presentation and Disclosure in Financial Statements.